Marker combination for prognosis evaluation of liver cirrhosis
A prognostic evaluation and marker technology, applied in the field of clinical medicine, can solve the problems of undetermined correlation of exhalation in patients with liver cirrhosis
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0034] 1. Study Participants
[0035] This study complies with the ethical principles of the World Medical Association Declaration of Helsinki. The experimental protocol was approved by the Ethics Committee of the Fifth Medical Center of the Chinese People's Liberation Army General Hospital and registered in the Chinese Clinical Trials Registry with the registration number ChiCTR-ROC-17010 345. April 2017 From January to October 2017, 96 participants, including 66 liver cirrhosis (DC) patients (33 males and 33 females) and 30 healthy volunteers (males), were recruited from the Fifth Medical Center of the Chinese People's Liberation Army General Hospital. 13 and 17 women), and all participants signed informed consent. Healthy volunteers (group C) were confirmed to be healthy through normal routine examinations within half a year. All diagnoses in 66 patients with cirrhosis, including 24 patients with hepatitis B cirrhosis (HLC), 22 patients with alcohol-related cirrhosis (ALC)...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap